Come up with a name for your new list and we'll add to it:
BioFactura raised a round of funding on , . Investors include
Frederick Innovative Technology Center.
BioFactura develops and commercializes biodefense drugs, client-selected novel drugs, and high-value biosimilars (i.e., follow-on biologics or generic biopharmaceuticals) using its patented StableFast…